1. P05.93 Adult medulloblastoma: analysis of use of chemotherapy in clinical practice. (19th September 2018) Authors: Mastall, M; Majd, N; Fuller, G; Gule-Monroe, M; Huse, J; Khatua, S; Rao, G; Sandberg, D; Wefel, J; Yeboa, D; Zaky, W; Mahajan, A; Puduvalli, V; Suki, D; Alfaro, K; Weathers, S; Harrison, R; de Groot, J; Penas-Prado, M Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii325 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P05.93 Adult medulloblastoma: analysis of use of chemotherapy in clinical practice. (19th September 2018) Authors: Mastall, M; Majd, N; Fuller, G; Gule-Monroe, M; Huse, J; Khatua, S; Rao, G; Sandberg, D; Wefel, J; Yeboa, D; Zaky, W; Mahajan, A; Puduvalli, V; Suki, D; Alfaro, K; Weathers, S; Harrison, R; de Groot, J; Penas-Prado, M Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii325 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. O-012Safety and effectiveness of regorafenib in patients with metastatic colorectal cancer (mCRC) in routine clinical practice: Final analysis from the prospective, observational CORRELATE study. (20th June 2018) Authors: Ducreux, M; Petersen, L; Öhler, L; Bergamo, F; Metges, J; de Groot, J; Wang, J; García Paredes, B; Kumar, N; Fiala-Buskies, S; Cervantes, A; O'Connor, J; Falcone, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P11.65.B GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple treatment regimens in newly diagnosed and recurrent glioblastoma. (5th September 2022) Authors: Weller, M; Ellingson, B; Alexander, B; Wen, P; Sulman, E; Colman, H; Berry, D; Tanner, K; Khasraw, M; Lim, M; Perry, J; Lassman, A; Cloughesy, T; Yung, W K A; Lee, E Q; Mellinghoff, I; Gordon, G; de Groot, J; Mikkelsen, T; Cavenee, W Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OS07.3.A Phase 1/2 clinical trial of blood-brain barrier opening with the SonoCloud-9 implantable ultrasound device in recurrent glioblastoma patients receiving IV carboplatin. (5th September 2022) Authors: Idbaih, A; Sonabend, A; Stupp, R; Chinot, O; Dufour, H; Ducray, F; Menei, P; de Groot, J; Desseaux, C; Carpentier, A Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P05.06 Phase 2 study to evaluate the safety, pharmacokinetics and clinical activity of PI3K/mTOR inhibitor GDC-0084 given to glioblastoma (GBM) patients with unmethylated O6-methylguanine-methyltransferase (MGMT) promoter status. (6th September 2019) Authors: Wen, P Y; de Groot, J; Battiste, J D; Goldlust, S A; Garner, J; Simpson, J; Olivero, A; Cloughesy, T Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗